Nr.
Eintrag
1
Ball, M C et al.: Wildlife forensics: "supervised" assignment testing can complicate the association of suspect cases to source populations.
2
Borry, Pascal et al.: Preconceptional genetic carrier testing and the commercial offer directly-to-consumers.
3
Hinton, Cynthia F ; Grant, Althea M ; Grosse, Scott D :Ethical implications and practical considerations of ethnically targeted screening for genetic disorders: the case of hemoglobinopathy screening.
4
Jordan, Bertrand :[The real « personal genome » ?]. = Le véritable « génome personnel » ?
5
Kuenzi, Donald E :Should doctors unionize for the purposes of collective bargaining?
6
Mariño, Tania Cruz et al.: Ethical dilemmas in genetic testing: examples from the Cuban program for predictive diagnosis of hereditary ataxias.
7
Maxwell, Susannah J et al.: Perceptions of population cystic fibrosis prenatal and preconception carrier screening among individuals with cystic fibrosis and their family members.
8
Muralidharan, Kasinathan et al.: Population carrier screening for spinal muscular atrophy a position statement of the Association for Molecular Pathology.
9
Ross, Lainie Friedman :Ethical and policy issues raised by heterozygote carrier identification and predictive genetic testing of adolescents.
10
Schenk, Maren :[Personalized genetic analysis]. = Prädiktive Gentests - für wen sind sie geeignet?
11
Bredenoord, A.L. et al.: Reproductive decision-making in the context of mitochondrial DNA disorders: views and experiences of professionals.
12
Gitlin, Jonathan M et al.: Carrier testing for spinal muscular atrophy.
13
Goldgar, Constance :GINA: What PAs need to know to protect patients and their families.
14
Ioannou, L et al.: Population-based genetic screening for cystic fibrosis: attitudes and outcomes.
15
Kiefer, Bertrand :[ Fund CPT / KPT: a hallucinatory story of enrichment. Insurance carriers]. = Caisse CPT/KPT: une hallucinante histoire d'enrichissement.
16
Maxwell, Susannah et al.: Informing policy for the Australian context - Costs, outcomes and cost savings of prenatal carrier screening for cystic fibrosis.
17
Mello, Michelle M. ; Gallagher, Thomas H. :Malpractice reform -- opportunities for leadership by health care institutions and liability insurers.
18
Miller, F.A. et al.: Consent for newborn screening: the attitudes of health care providers.
19
Miller, Fiona A. et al.: Consent for newborn screening: the attitudes of health care providers.
20
Modra, Lucy J ; Massie, R John ; Delatycki, Martin B :Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening.
